CRG Investments

CRG is a private healthcare-focused investment firm that provides flexible growth capital rather than operating as a drug developer. The firm invests across life sciences, consumer health, medical technology, healthcare services, diagnostics, and healthcare IT, primarily supporting commercial-stage public and private companies. Its core strategy is healthcare private credit, complemented by selective equity investments, with transaction structures intended to minimize dilution for portfolio companies. Founded in 2003, CRG has managed more than $4 billion in institutional capital and has completed dozens of healthcare investments globally. For biotech analysts, CRG is best understood as a specialist healthcare financier and strategic investment partner, not as a therapeutics pipeline company.